Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Omeros CorporationNASDAQ: OMER
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $239K fell 17.3% year over year, behind the -11.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.7% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.
Context
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -17.3% toward the trailing-twelve-month pace of -11.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 964K USD
- Year-over-year change
- +1.5%
- 4-year CAGR
- -8.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 964K | +1.5% |
| FY2024 | 2024-12-31 | 950K | +3.3% |
| FY2023 | 2023-12-31 | 920K | -3.4% |
| FY2022 | 2022-12-31 | 952K | -31.3% |
| FY2021 | 2021-12-31 | 1.39M | — |
Depreciation & Amortization vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 depreciation & amortization of $914K is the 7th highest of the 11 companies compared; the peer median is $1.84M.
- Its year-over-year change of -11.7% is the 9th highest of 10, against a peer median of +1.2%.
- Depreciation & amortization amounts to 9.2% of revenue for OMER, versus a peer median of 4.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $10.67M | +22.9% | +92.7% | — | |
| LTM Jun 2026 | $10.17M | -10.7% | +6.1% | 9.7% | |
| LTM Jun 2026 | $10M | +0.0% | +18.6% | 8.5% | |
| LTM Mar 2026 | $7.09M | -5.1% | -15.4% | 4.5% | |
| LTM Mar 2026 | $2.43M | +1.2% | +1.2% | 1.0% | |
| LTM Mar 2026 | $1.25M | +15.6% | +8.7% | 249.7% | |
| LTM Mar 2026 | $914K | -11.7% | +0.4% | 9.2% | |
| LTM Jun 2026 | $537K | -72.7% | -56.2% | 1.0% | |
| LTM Mar 2026 | $314K | +2.6% | +49.5% | — | |
| LTM Mar 2026 | $112K | +33.3% | -34.1% | — | |
| LTM Mar 2026 | $0 | — | -0.5% | 0.0% | |
| Peer median (excluding OMER) | $1.84M | +1.2% | +3.7% | 4.5% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| Weighted Avg Shares | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
| Weighted Avg Shares (Diluted) | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.